Types of Stem Cells: Mesenchymal, Embryonic, Induced – What’s the Difference?
- Revival Clinic Team
- Jul 20
- 4 min read

As stem cell therapy becomes increasingly popular among international patients seeking anti-aging and regenerative solutions, it’s essential to understand the different types of stem cells used in modern medicine. Each type comes with unique benefits, risks, and ethical considerations.
At Revival Clinic Bangkok, we specialize in safe, high-quality mesenchymal stem cell (MSC) therapy that aligns with global standards. In this guide, we’ll explore the main types of stem cells — mesenchymal, embryonic, and induced pluripotent (iPSC) — and help you understand which is most suitable for medical use today.
Understanding the Basics: What Are Stem Cells?
Stem cells are undifferentiated cells with the potential to develop into various specialized cell types. They play a vital role in tissue regeneration, immune modulation, and healing processes.
Broadly, stem cells are categorized into:
Pluripotent stem cells: Can become nearly any cell type in the body
Multipotent stem cells: Can become a limited range of cell types
The three main types used or studied in regenerative medicine are embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and mesenchymal stem cells (MSCs).
Mesenchymal Stem Cells (MSCs): The Clinical Gold Standard
Mesenchymal stem cells are multipotent adult stem cells found in tissues like:
Umbilical cord (Wharton’s Jelly)
Adipose (fat) tissue
Bone marrow
Key Benefits:
Immunomodulatory: Help regulate immune responses and reduce inflammation
Anti-aging effects: Improve mitochondrial function, reduce oxidative stress
Ethically sourced: Typically obtained from donated umbilical cords or adult tissues
Clinically safe: Do not form tumors or uncontrolled growths
MSCs are widely used in anti-aging, autoimmune diseases, orthopedic issues, and post-viral recovery (e.g., long COVID). At Revival Clinic, we exclusively use xeno-free, lab-expanded MSCs cultured under GMP-certified conditions to ensure patient safety.
Research published in Stem Cells International (2021) confirms the safety and efficacy of MSCs in clinical trials for inflammation, cartilage repair, and immune modulation.
Embryonic Stem Cells (ESCs): Powerful but Controversial
Embryonic stem cells are pluripotent, meaning they can become any cell type. They are derived from early-stage embryos (blastocysts), typically donated from IVF procedures.
Potential:
Can theoretically regenerate any tissue or organ
Used heavily in research and drug discovery
Challenges:
Ethical concerns: Use of human embryos is controversial in many countries
Tumor risk: ESCs can form teratomas (tumor-like growths) if not controlled
Not approved for routine clinical use in most countries
ESC-based therapies remain largely experimental and are not offered at Revival Clinic or in mainstream clinical practice due to these concerns.
Induced Pluripotent Stem Cells (iPSCs): Reprogrammed Possibilities
Induced pluripotent stem cells are adult cells (usually skin or blood cells) that are genetically reprogrammed to behave like embryonic stem cells.
Advantages:
Pluripotent like ESCs, without using embryos
Can be created from the patient’s own cells (autologous)
Limitations:
Costly and complex to produce
Risk of genetic mutations or immune rejection
Still under research and not widely used in clinical practice
A review in Nature Biotechnology (2020) emphasizes that while iPSCs have great long-term promise, they require strict genetic monitoring due to mutation risks during reprogramming.
At present, iPSCs are primarily used in lab research, disease modeling, and early-phase trials — not in routine patient care.
Why Revival Clinic Uses Only Mesenchymal Stem Cells
At Revival Clinic Bangkok, we focus exclusively on mesenchymal stem cell therapy because it is:
Safe and well-studied
Ethically sourced from healthy umbilical cord tissue
Supported by thousands of clinical cases worldwide
We do not use embryonic or induced pluripotent stem cells in any treatment, in line with international best practices.
Our patients — including those from Singapore, the UAE, Australia, and the US — choose Revival Clinic for our strict protocols, experienced team, and excellent outcomes.
Learn more about our stem cell treatment in Bangkok.
Summary Table: Comparing Stem Cell Types
Type | Source | Pluripotent? | Clinical Use | Risk Level | Ethical Concerns |
Mesenchymal (MSC) | Umbilical cord, fat, bone marrow | No | Widely used | Low | None |
Embryonic (ESC) | Human embryos (blastocysts) | Yes | Experimental | High (tumors) | High |
Induced (iPSC) | Reprogrammed adult cells | Yes | Experimental | Medium–High | Low |
FAQ
Q: Are mesenchymal stem cells the safest option?
Yes. MSCs have the lowest risk of side effects, do not form tumors, and are the most widely studied and applied in clinical practice.
Q: Can I choose between these stem cell types?
Most clinics worldwide, including Revival Clinic, use only MSCs for safety, legality, and effectiveness.
Q: Are MSCs from my own body better than donor cells?
In many cases, donor umbilical cord MSCs are more potent and safer, especially for patients over 40, whose own stem cells may have aged.
Ready to Explore Stem Cell Therapy in Bangkok?
Whether you're exploring anti-aging solutions, managing chronic inflammation, or simply looking for the most advanced regenerative care, Revival Clinic Bangkok is here to guide you.
Our internationally trained team offers personalized treatment plans, premium service, and transparent communication every step of the way.
Contact us today to schedule your consultation and discover how stem cell therapy can support your long-term health goals.
References
Squillaro, T., Peluso, G., & Galderisi, U. (2016). Clinical trials with mesenchymal stem cells: An update. Cell Transplantation, 25(5), 829–848. https://doi.org/10.3727/096368915X689622
Trounson, A., & McDonald, C. (2015). Stem cell therapies in clinical trials: Progress and challenges. Cell Stem Cell, 17(1), 11–22. https://doi.org/10.1016/j.stem.2015.06.007
Zakrzewski, W., Dobrzynski, M., Szymonowicz, M., & Rybak, Z. (2019). Stem cells: Past, present, and future. Stem Cell Research & Therapy, 10, 68. https://doi.org/10.1186/s13287-019-1165-5
Robinton, D. A., & Daley, G. Q. (2012). The promise of induced pluripotent stem cells in research and therapy. Nature, 481(7381), 295–305. https://doi.org/10.1038/nature10761
Shi, Y., Inoue, H., Wu, J. C., & Yamanaka, S. (2017). Induced pluripotent stem cell technology: A decade of progress. Nature Reviews Drug Discovery, 16(2), 115–130. https://doi.org/10.1038/nrd.2016.245
Lee, M. et al. (2021). Safety and efficacy of mesenchymal stem cell therapy for autoimmune diseases. Stem Cells International, 2021, Article ID 8870210. https://doi.org/10.1155/2021/8870210
Comments